Dr Reddy’s Laboratories

US FDA warns of serious data integrity violations at DRL

Read more

DRL welcomes govt’s move on simplifying taxation laws

Read more

Dr Reddy’s completes Fondaparinux IP purchase

Read more

Arogya Finance and DRL collaborate to provide medical loans for financially weak

Read more

DRL issues statement on receipt of warning letter from US FDA

Read more

DRL to market Biocodex products in Romania

Read more

Helsinn Healthcare in agreement with DRL

Read more

DRL launches esomeprazole magnesium delayed-release capsules

Read more

Dr Reddy’s, BioMarin settle patent litigation on Kuvan tablets

Read more

DRL partners with PanTheryx

Read more